Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine
Nature Biotechnology
2010
28
3
264-270
A Secreted Enzyme Reporter System for MRI
Angewandte Chemie International Edition
2010
49
23
3909-3911
Evaluation of the attenuation properties of MR equipment for its use in a whole-body PET/MR scanner.
Phys Med Biol
2010
55
15
4361-74
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.
Thyroid
2010
20
5
527-33
Synthesis, biological evaluation and radiolabelling by 18F-fluoroarylation of a dopamine D3-selective ligand as prospective imaging probe for PET.
Bioorg Med Chem Lett
2010
20
23
6933-7
One-Step (18)F-Labeling of Carbohydrate-Conjugated Octreotate-Derivatives Containing a Silicon-Fluoride-Acceptor (SiFA): In Vitro and in Vivo Evaluation as Tumor Imaging Agents for Positron Emission Tomography (PET).
Bioconjug Chem
2010
21
12
2289-2296
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.
Eur J Nucl Med Mol Imaging
2010
37
1
181-200
Caffeine and cognition in functional magnetic resonance imaging.
J Alzheimers Dis
2010
20 Suppl 1
S71-84
Lesion concordance, image quality and artefacts in PET/CT: results of a multicenter study.
Nuklearmedizin
2010
49
4
129-37